Truscreen Group Ltd (tru) Logo

Truscreen Group Ltd (TRU)

___:___ · Healthcare

TRU Chart


TRU's Principal Activity is the owns the rights to the TruScreen Cervical Cancer Screening Device. The device comprises a medical device and process designed to detect the presence in real time of precancerous and cancerous tissue on the cervix.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -21.80%


Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,716 of 2,413
Sector Rank 159 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies ATX / ICS / SUD
EPS -$0.01
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

TRU is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Date Heading Pages File Size Time

Corporate Overview

TruScreen Group Limited (TRU) is a New Zealand-based medical device company that has developed an AI-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. TruScreen is currently targeting product sales to a range of low and middle-income countries, including China, Mexico, Vietnam, Russia, and Saudi Arabia.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Sydney NSW 2000
Registry Link Market Services
Auditor RSM Hayes Audit
Date Listed 6 Jan 2021

Upcoming Calendar (Forecasted)

Date Event
30/05/2022 Report (Prelim)
29/06/2022 Report (Annual)
28/11/2022 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
15/10/2013 $0.17 100% $0.2429 Interim 05/11/2013
29/04/2013 $0.18 100% $0.2571 Final 17/05/2013
17/10/2012 $0.12 100% $0.1714 Interim 08/11/2012
02/05/2012 $0.18 100% $0.2571 Final 24/05/2012
22/11/2011 $0.17 100% $0.2429 Interim 14/12/2011
27/04/2011 $0.18 100% $0.2571 Final 16/05/2011
21/10/2010 $0.17 100% $0.2429 Interim 11/11/2010
05/05/2010 $0.165 100% $0.2357 Final 25/05/2010
22/10/2009 $0.172 100% $0.2457 Interim 12/11/2009
30/04/2009 $0.22 100% $0.3143 Final 20/05/2009

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio --
DRP Features -

Directors & Management

Directors & Management

Name Title Since Bio
Dr Dexter Cheung Non-Executive Director Mar 2021

Dr Dexter Cheung

Non-Executive Director

Dr Cheung have more than 20 years experience. He is the Research & Development Manager of the respiratory humidification division of Fisher & Paykel Healthcare, an NZX/ASX listed healthcare company and a global leader in respiratory medical devices. Dr Cheung is memeber of Risk and Finance Committee.

Ms Juliet Hull Chief Executive Officer,Executive Director Sep 2020

Ms Juliet Hull

Chief Executive Officer,Executive Director

Ms Hull was until January 2021 the NZ General Manager/ Country Director of Johnson & Johnson Medical (J & J), a director of the ANZ Johnson & Johnson Medical Executive Board, a director of MTANZ (Medical Technology Association of NZ) and amember of both the APAC Regional Leadership team for J & J's Orthopaedics and Ethicon Divisions. Ms Hull is a senior executive with more than 20 years experience in Asia Pacific markets in Healthcare sales, marketing and leadership. Ms Hull is currently acting as the interim CEO of TruScreen.

Mr Guy Adrian Robertson Chief Financial Officer,Company Secretary Nov 2018
Mr Anthony (Tony) Peng Ho Non-Executive Chairman,Non-Executive Director Oct 2018

Mr Anthony (Tony) Peng Ho

Non-Executive Chairman,Non-Executive Director

Mr Ho is an experienced company director having held executive directorships and chief financial officer roles with a number of ASX listed companies. Mr Ho was executive director of Arthur Yates & Co Limited, retiring from that position in April 2002. His corporate, general management and governance experience includes being chief financial officer/finance director of M.S. McLeod Holdings Limited, Galore Group Limited, the Edward H O'Brien group of companies. He was previously chairman of Esperance Minerals Limited and Credit Intelligence Limited and a non-executive director Hastings Technology Metals Limited. Mr Ho was the past nonexecutive chairman of St. George Community Housing Limited (November 2002 to December 2009) where he successfully grew the NGO to be one of New South Wales leading community housing companies. Prior to joining commerce, Mr Ho was a partner of Cox Johnston & Co, Chartered Accountants, which has since merged with Ernst & Young.

Mr Christopher Horn Non-Executive Director Nov 2013

Mr Christopher Horn

Non-Executive Director

Mr Horn is an experienced business executive and has acted in a number of management roles including 20 years as a partner of KPMG and its predecessor firms. He is a director of a number of private companies across a broad range of business activities including corporate advisory, financial services and funds management. He is chairman of Finance and Risk Committee.

Guy Robertson Chief Financial Officer N/A
Edmond Capcelea Chief Technology Officer N/A

Director Transactions

TRU directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
27/09/21 Dexter Cheung Buy +100,000 $0.06 $6,030 On-market trade
03/08/21 Christopher (Chris) Lawrence Sell +1,406,913 $0.065 ($90,869) On-market trade
29/07/21 Anthony (Tony) Ho Buy +100,000 $0.062 $6,200 On-market trade
20/07/21 Christopher (Chris) Lawrence Sell +4,467,169 $0.068 ($302,302) On-market trade
12/07/21 Anthony (Tony) Ho Expiry 1,000,000 $0.068 $68,000 Options expired
02/07/21 Christopher (Chris) Lawrence Sell +1,465,695 $0.069 ($101,761) On-market trade
02/06/21 Christopher (Chris) Lawrence Sell +418,818 $0.078 ($32,736) On-market trade
06/01/21 Anthony (Tony) Ho Buy +100,000 $0.09 $9,000 On-market trade

Director Interests

The current holdings of TRU directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Dexter Cheung 28/12/2021 100,000 N/A 1,000,000 N/A
Juliet Hull 28/12/2021 N/A N/A 1,000,000 N/A
Anthony (Tony) Ho 29/07/2021 N/A 3,700,000 2,000,000 N/A
Christopher Horn 31/03/2021 2,050,000 N/A 1,000,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Jun 15, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
New Zealand Depository Nominee <1 A/C> 30,459,778 8.39%
Consolidated Nominees Pty Ltd <ARF The Robair Investment Trust A/C> 29,539,900 8.14%
Browns Island Holdings Limited 21,658,411 5.97%
Waitara Trustees Limited 18,622,222 5.13%
Masfen Securities Limited 13,499,645 3.72%
New Zealand Central Securities 11,847,611 3.27%
Albert Nominees Limited 11,000,000 3.03%
Consolidated Nominees Pty Ltd <Atk Rkh Superannuation Fund A/C> 10,062,500 2.77%
Idl Trustee Limited 9,850,000 2.71%
Lah Investment Co Pty Limited <Lah Superannuation Fund A/C> 9,056,330 2.50%
Ryan Peter Parkin 5,300,000 1.46%
Maarten Arnold Janssen 4,964,170 1.37%
Forsyth Barr Custodians 4,502,610 1.24%
David Russell Stewart & Adrienne Ruth Stewart 4,138,995 1.14%
Caroline Robyn Ball & Christopher John Thomson Bush 2,978,681 0.82%
Custodial Services Limited <4 A/C> 2,455,999 0.68%
Anthony Peng Ho & Chui Hoong Ho <AP & CH Super Fund A/C> 2,400,000 0.66%
QSP Limited 2,312,790 0.64%
Christopher Lawrence Horn & Marilyn Gai Horn <The C L Horn Super Fund A/C> 2,050,000 0.56%
Margot Jean Ainsworth 2,000,000 0.55%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 40 326 453 775 253 1,847

Substantial Shareholders

No Substantial Shareholders for TRU in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.058 30 June
TRU Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.